Premier Inc.

04/08/2026 | Press release | Distributed by Public on 04/08/2026 10:24

Court vacates 340B policy on hospital drug purchasing: 6 things to know


*:last-child]:mb-0 [&>*:last-child]:pb-0 [&>p]:font-normal text-left [&>.prm-button-bar]:justify-start [&_.portable-text-link]:font-semibold [&_.portable-text-link]:underline [&_.prm-button-bar_a]:no-underline [&_li]:text-light-gray [&_p]:text-light-gray">

Becker's Hospital Review reports that a federal court vacated a 2013 Health Resources and Services Administration (HRSA) policy restricting how certain 340B hospitals purchase drugs, ruling the agency failed to adequately justify its decision. The case was brought by Premier Inc., which challenged the policy after HRSA declined to exempt its purchasing arrangement.

Read more from Becker's Hospital Review.

Premier Inc. published this content on April 08, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 08, 2026 at 16:24 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]